What if

you found cancer early enough to make a difference

Beating cancer starts
with knowing you have it

Finding cancer early is important to improve treatment outcomes and survival.1

The vast majority of cancers show no symptoms until later stages, when treatment options may be limited.2 Today, many cancers are found too late, when outcomes are often deadly.3

71% of cancer deaths are caused by cancers not commonly screened for 71% of cancer deaths are caused by cancers not commonly screened for

Multi-cancer early detection enables you to proactively test for many cancers, increasing the chances of finding cancer early.

Getting tested

The Galleri test can be included in a routine visit with your healthcare provider through a simple blood draw. Talk to your healthcare provider today about your risk for cancer, and whether the Galleri test is right for you. 

The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. It is intended to be used in addition to and not replace other cancer screening tests your healthcare provider recommends.

Not all cancers can be detected by the Galleri test. Your healthcare provider will discuss appropriate follow-up testing to confirm if cancer is present.

Speak to your healthcare provider to learn more

We’ll help you get the conversation started with a patient + provider discussion guide that you can download and take with you.

We’re here to help

If you have questions or would like to know more,
contact us or see our FAQs.

Sign up for more information about the Galleri test

  1. Surveillance, Epidemiology, and End Results (SEER) Program (www​.seer​.can​cer​.gov) SEER*Stat Database: Incidence — SEER 18 Regs Research Data. Nov 2018 Sub. Includes persons aged 50 – 79 diagnosed 2006 – 2015. Early/​Localized” includes invasive localized tumors that have not spread beyond organ of origin. Late/​Metastasized” includes invasive cancers that have metastasized beyond the organ of origin to other parts of the body.
  2. Cancer Facts and Figures 2021https://​www​.can​cer​.org/​c​o​n​t​e​n​t​/​d​a​m​/​c​a​n​c​e​r​-​o​r​g​/​r​e​s​e​a​r​c​h​/​c​a​n​c​e​r​-​f​a​c​t​s​-​a​n​d​-​s​t​a​t​i​s​t​i​c​s​/​a​n​n​u​a​l​-​c​a​n​c​e​r​-​f​a​c​t​s​-​a​n​d​-​f​i​g​u​r​e​s​/​2​0​2​1​/​c​a​n​c​e​r​-​f​a​c​t​s​-​a​n​d​-​f​i​g​u​r​e​s​-​2​0​2​1.pdf
  3. Siegel RL, et al. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7 – 33. doi: 10.3322/caac.21654.
  4. Modeled detection extrapolated to 2020 US population ages 50 – 79. Screening includes methods with United States Preventive Services Task Force (USPSTF) A, B, or C rating (breast, colon, cervical, prostate, and lung), and assumes screening is available for all prostate, breast, cervical, and colorectal cancer cases and 33% of lung cancer cases (based on estimated proportion of lung cancers that occur in screen-eligible individuals older than 40 years).
  5. Data on file from Surveillance, Epidemiology, and End Results (SEER) 18 Regs Research Data, Nov 2017 Submission. Includes persons aged 50 – 79. Estimated deaths per year in 2020 from American Cancer Society Cancer Facts and Figures 2020. Available at: www​.can​cer​.org/​c​o​n​t​e​n​t​/​d​a​m​/​c​a​n​c​e​r​-​o​r​g​/​r​e​s​e​a​r​c​h​/​c​a​n​c​e​r​-​f​a​c​t​s​-​a​n​d​-​s​t​a​t​i​s​t​i​c​s​/​a​n​n​u​a​l​-​c​a​n​c​e​r​-​f​a​c​t​s​-​a​n​d​-​f​i​g​u​r​e​s​/​2​0​2​0​/​c​a​n​c​e​r​-​f​a​c​t​s​-​a​n​d​-​f​i​g​u​r​e​s​-​2​0​2​0.pdf
  6. The Galleri test does not detect all cancers nor does it measure your genetic risk of developing cancer in the future. It should be used in addition to routine screening tests your healthcare provider recommends.
  7. Klein EA, Richards D, Cohn A, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test. Abstract LB013. Presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting April 10 – 15, 2021.
  8. Amin MB, et al. (Eds). American Joint Committee of Cancer (AJCC) Cancer Staging Manual (8th edition)
CHAT